Evidence
Annu Rev Med. 2023 Sep 20. doi: 10.1146/annurev-med-051322-120608. Online ahead of print.
ABSTRACT
Major depressive disorder (MDD) is a leading cause of suicide in the world. Monoamine-based antidepressant drugs are a primary line of treatment for this mental disorder, although the delayed response and incomplete efficacy in some patients highlight the need for improved therapeutic approaches. Over the past two decades, ketamine has shown rapid onset with sustained (up to several days) antidepressant effects in patients whose MDD has not responded to conventional antidepressant drugs. Recent preclinical studies have started to elucidate the underlying mechanisms of ketamine’s antidepressant properties. Herein, we describe and compare recent clinical and preclinical findings to provide a broad perspective of the relevant mechanisms for the antidepressant action of ketamine. Expected final online publication date for the Annual Review of Medicine, Volume 75 is January 2024. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.
PMID:37729028 | DOI:10.1146/annurev-med-051322-120608
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Ketamine: Mechanisms and Relevance to Treatment of Depression
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- Ketamine metabolism via hepatic CYP450 isoforms contributes to its sustained antidepressant actions
- Thalamocortical functional connectivity and rapid antidepressant and antisuicidal effects of low-dose ketamine infusion among patients with treatment-resistant depression
- Subanesthetic S-ketamine does not acutely alter striatal dopamine transporter binding in healthy Sprague Dawley female rats
- A randomised, open-label, pragmatic pilot comparison of oral and intravenous ketamine in treatment-resistant depression
- A randomised, open-label, pragmatic pilot comparison of oral and intravenous ketamine in treatment-resistant depression
- The Use of Ketamine for the Treatment of Anhedonia in Depression
- Hippocampal PACAP signaling activation triggers a rapid antidepressant response
- Hippocampal PACAP signaling activation triggers a rapid antidepressant response
- A Systematic Review on Ketamine and Esketamine for Treatment-Resistant Depression and Suicidality in Adolescents: A New Hope?
- Predicting treatment response to ketamine in treatment-resistant depression using auditory mismatch negativity: Study protocol
- Suicidal ideation following ketamine prescription in patients with recurrent major depressive disorder: a nation-wide cohort study
- Suicidal ideation following ketamine prescription in patients with recurrent major depressive disorder: a nation-wide cohort study
- Up-to-Date on clinical and preclinical studies of psilocybin therapy
- A genome-wide association study of escitalopram treatment outcomes in patients with major depressive disorder
- Repurposing General Anesthetic Drugs to Treat Depression: A New Frontier for Anesthesiologists in Neuropsychiatric Care
- Therapeutic Potential of Psychedelic Drugs: Navigating High Hopes, Strong Claims, Weak Evidence, and Big Money
- Functional changes in sleep-related arousal after ketamine administration in individuals with treatment-resistant depression
- Immune-Targeted Therapies for Depression: Current Evidence for Antidepressant Effects of Monoclonal Antibodies
- Immune-Targeted Therapies for Depression: Current Evidence for Antidepressant Effects of Monoclonal Antibodies
- Immune-Targeted Therapies for Depression: Current Evidence for Antidepressant Effects of Monoclonal Antibodies
- Suicidal ideation following ketamine prescription in patients with recurrent major depressive disorder: a nation-wide cohort study
- Common polygenic variation in the early medication change (EMC) cohort affects disorder risk, but not the antidepressant treatment response
- Depression with comorbid borderline personality disorder - could ketamine be a treatment catalyst?
- Role of oxidative phosphorylation in the antidepressant effects of arketamine via the vagus nerve-dependent spleen-brain axis
- Effect of Time From Onset of Major Depressive Disorder on the Therapeutic Response to Esmethadone (REL-1017)
- Curcumin and nano-curcumin applications in psychiatric disorders
- Antidepressant-associated diagnostic change from major depressive to bipolar disorder
- The impact of antidepressant treatment on the network structure of neurocognition and core emotional depressive symptoms among depressed individuals with a history of suicide attempt: An 8-week clinical study
- Widespread reductions in cortical thickness following ketamine abuse
- Alzheimer Disease-Link With Major Depressive Disorder and Efficacy of Antidepressants in Modifying its Trajectory
- Neuroanatomical dimensions in medication-free individuals with major depressive disorder and treatment response to SSRI antidepressant medications or placebo
- A meta-analysis of the effects of ketamine on suicidal ideation in depression patients
- Improvement in depressive symptoms in a patient with severe and enduring anorexia nervosa and comorbid major depressive disorder using psychotherapy-assisted IV ketamine : a case report
- The role of BDNF transcription in the antidepressant-like effects of 18β-glycyrrhetinic acid in a chronic social defeat stress model
- Ketamine for catatonia: A novel treatment for an old clinical challenge? A systematic review of the evidence
- The bidirectional interaction between antidepressants and the gut microbiota: are there implications for treatment response?
- Cognitive changes in patients with unipolar TRD treated with IV ketamine: A systematic review
- Cognitive changes in patients with unipolar TRD treated with IV ketamine: A systematic review
- Is there evidence for using ketamine among individuals with dementia?
- Oral ketamine effects on dynamics of functional network connectivity in patients treated for chronic suicidality
- Pre- And Post-Synaptic Protein In The Major Depressive Disorder: From Neurobiology To Therapeutic Targets
- Adolescent and Adult Transitions From Major Depressive Disorder to Bipolar Disorder
- Effects of Low-Dose Ketamine Infusion on the Positive and Negative Domains of Hopelessness and Suicidal Thoughts
- A multicenter retrospective study of antidepressant use in outpatient clinics in China pre- and post-COVID
- Management of Depression in Adults: A Review
- Association between maternal antidepressant use during pregnancy and the risk of autism spectrum disorder and attention deficit hyperactivity disorder in offspring
- Non-improvement predicts subsequent non-response to repeated-dose intravenous ketamine for depression: a re-analysis of a 2-week open-label study in patients with unipolar and bipolar depression
- Antidepressant drug use after intensive care: a nationwide cohort study
- Molecular signatures of astrocytes and microglia maladaptive responses to acute stress are rescued by a single administration of ketamine in a rodent model of PTSD
- Ketamine Self-Medication in a Patient with Autism Spectrum Disorder and Comorbid Therapy-Resistant Depression
- Ketamine Self-Medication in a Patient with Autism Spectrum Disorder and Comorbid Therapy-Resistant Depression
- Role of Electroconvulsive Therapy, Ketamine Infusion, and Deep Repetitive Transcranial Magnetic Stimulation in Treatment-Resistant Bipolar Depression: A Case Report
- Impact of Prolonged Continuous Ketamine Infusions in Critically Ill Children: A Prospective Cohort Study
- Underlying mechanisms for psychotropic effects of delta opioid receptor agonists
- Ketamine Therapy in Complex Cases: A Cautionary Tale of Exacerbated Personality Traits and the Crucial Role of Comprehensive Follow-Up and Psychosocial Interventions
- Ketamine in the effective management of chronic pain, depression, and posttraumatic stress disorder for Veterans: A meta-analysis and systematic review
- Seasonality and sun exposure in incidence of major depression, bipolar disorder, and first-time use of antidepressant medication
- DSP-6745, a novel 5-hydroxytryptamine modulator with rapid antidepressant, anxiolytic, antipsychotic and procognitive effects
- Effectiveness of buccal administration of dexmedetomidine and ketamine combination in paediatric dental sedation: A randomized controlled clinical trial
- Treating depression in patients with borderline personality disorder: clinical clues on the use of antidepressants
- Accelerated Intermittent Theta-Burst Stimulation and Treatment-Refractory Bipolar Depression: A Randomized Clinical Trial
- GPR56: A potential therapeutic target for neurological and psychiatric disorders
- Three-needle electroacupuncture ameliorates depressive-like behaviors in a mouse model of post-stroke depression by promoting excitatory synapse formation via the NGL-3/L1cam pathway
- Three-needle electroacupuncture ameliorates depressive-like behaviors in a mouse model of post-stroke depression by promoting excitatory synapse formation via the NGL-3/L1cam pathway
Evidence Blueprint
Ketamine: Mechanisms and Relevance to Treatment of Depression
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Ketamine: Mechanisms and Relevance to Treatment of Depression
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- Ketamine and its enantiomers for depression: a bibliometric analysis from 2000 to 2023
- Ketamine and its enantiomers for depression: a bibliometric analysis from 2000 to 2023
- Ketamine's mechanism of action with an emphasis on neuroimmune regulation: can the complement system complement ketamine's antidepressant effects?
- Ketamine metabolism via hepatic CYP450 isoforms contributes to its sustained antidepressant actions
- Are "mystical experiences" essential for antidepressant actions of ketamine and the classic psychedelics?
- The Efficacy and Safety of Intranasal Formulations of Ketamine and Esketamine for the Treatment of Major Depressive Disorder: A Systematic Review
- Have Effective Antidepressants Finally Arrived? Developments in Major Depressive Disorder Therapy
- Ketamine and the neurobiology of depression: Toward next-generation rapid-acting antidepressant treatments
- Neurophysiological evidence that frontoparietal connectivity and GABA-A receptor changes underpin the antidepressant response to ketamine
- Exploring Predictors of Ketamine Response in Adolescent Treatment-Resistant Depression
- Thalamocortical functional connectivity and rapid antidepressant and antisuicidal effects of low-dose ketamine infusion among patients with treatment-resistant depression
- Subanesthetic S-ketamine does not acutely alter striatal dopamine transporter binding in healthy Sprague Dawley female rats
- Rapid and sustained antidepressant effects of intravenous ketamine in treatment-resistant major depressive disorder and suicidal ideation: a randomized clinical trial
- A randomised, open-label, pragmatic pilot comparison of oral and intravenous ketamine in treatment-resistant depression
- A randomised, open-label, pragmatic pilot comparison of oral and intravenous ketamine in treatment-resistant depression
- Does the intensity of dissociation predict antidepressant effects 24 hours after infusion of racemic ketamine and esketamine in treatment-resistant depression? A secondary analysis from a randomized controlled trial
- Biological markers of sex-based differences in major depressive disorder and in antidepressant response
- The Use of Ketamine for the Treatment of Anhedonia in Depression
- Hippocampal PACAP signaling activation triggers a rapid antidepressant response
- Hippocampal PACAP signaling activation triggers a rapid antidepressant response
- A Randomized, Double-Blind, Placebo-Controlled Pilot Trial of the Acute Antisuicidal and Antidepressant Effects of Intranasal (R,S)-Ketamine in Severe Unipolar and Bipolar Depression With and Without Comorbid Alcohol Use Disorder
- A Systematic Review on Ketamine and Esketamine for Treatment-Resistant Depression and Suicidality in Adolescents: A New Hope?
- Comparison of ketamine with buprenorphine as adjunctive therapy in the treatment of comorbid major depressive disorder and opium use disorders: A randomized controlled trial
- Predicting treatment response to ketamine in treatment-resistant depression using auditory mismatch negativity: Study protocol
- Suicidal ideation following ketamine prescription in patients with recurrent major depressive disorder: a nation-wide cohort study
- Suicidal ideation following ketamine prescription in patients with recurrent major depressive disorder: a nation-wide cohort study
- Ketamine for treatment-resistant major depressive disorder: Double-blind active-controlled crossover study
- Up-to-Date on clinical and preclinical studies of psilocybin therapy
- A genome-wide association study of escitalopram treatment outcomes in patients with major depressive disorder
- Astroglial Connexin 43-Mediated Gap Junctions and Hemichannels: Potential Antidepressant Mechanisms and the Link to Neuroinflammation
- Randomized trial of ketamine masked by surgical anesthesia in patients with depression
- Personality traits predict treatment outcome of an antidepressant in untreated adolescents with depression: An 8-week, open-label, flexible-dose study
- Repurposing General Anesthetic Drugs to Treat Depression: A New Frontier for Anesthesiologists in Neuropsychiatric Care
- Therapeutic Potential of Psychedelic Drugs: Navigating High Hopes, Strong Claims, Weak Evidence, and Big Money
- Exploring Esketamine's Therapeutic Outcomes as an FDA-Designated Breakthrough for Treatment-Resistant Depression and Major Depressive Disorder With Suicidal Intent: A Narrative Review
- Brain-derived neurotrophic factor Val66Met and CYP2B6 polymorphisms as predictors for ketamine effectiveness in patients with treatment-resistant depression
- Transcriptional signatures of early-life stress and antidepressant treatment efficacy
- Functional changes in sleep-related arousal after ketamine administration in individuals with treatment-resistant depression
- Real-World Effectiveness of Repeated Ketamine Infusions for Treatment-Resistant Bipolar Depression
- Brain-based correlates of antidepressant response to ketamine: a comprehensive systematic review of neuroimaging studies
- Ketamine use in pediatric depression: A systematic review
- cAMP-dependent protein kinase signaling is required for (2R,6R)-hydroxynorketamine to potentiate hippocampal glutamatergic transmission
- Immune-Targeted Therapies for Depression: Current Evidence for Antidepressant Effects of Monoclonal Antibodies
- Immune-Targeted Therapies for Depression: Current Evidence for Antidepressant Effects of Monoclonal Antibodies
- Immune-Targeted Therapies for Depression: Current Evidence for Antidepressant Effects of Monoclonal Antibodies
- Suicidal ideation following ketamine prescription in patients with recurrent major depressive disorder: a nation-wide cohort study
- Ketamine, an Old-New Drug: Uses and Abuses
- Common polygenic variation in the early medication change (EMC) cohort affects disorder risk, but not the antidepressant treatment response
- Very Low-Dose Sublingual Ketamine for Borderline Personality Disorder and Treatment-Resistant Depression
- Short-term ketamine use in bipolar depression: a review of the evidence for short-term treatment management
- Depression with comorbid borderline personality disorder - could ketamine be a treatment catalyst?
- Depression with comorbid borderline personality disorder - could ketamine be a treatment catalyst?
- Role of oxidative phosphorylation in the antidepressant effects of arketamine via the vagus nerve-dependent spleen-brain axis
- Network pharmacology and experimental evidence: ERK/CREB/BDNF signaling pathway is involved in the antidepressive roles of Kaiyu Zhishen decoction
- Effect of Time From Onset of Major Depressive Disorder on the Therapeutic Response to Esmethadone (REL-1017)
- Curcumin and nano-curcumin applications in psychiatric disorders
- Antidepressant-associated diagnostic change from major depressive to bipolar disorder
- Role of trazodone in treatment of major depressive disorder: an update
- The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data
- The impact of antidepressant treatment on the network structure of neurocognition and core emotional depressive symptoms among depressed individuals with a history of suicide attempt: An 8-week clinical study
- Psychedelic Therapy: A Primer for Primary Care Clinicians-Ketamine
- The Study of Ketamine for Youth Depression (SKY-D): study protocol for a randomised controlled trial of low-dose ketamine for young people with major depressive disorder
- Current concepts in ketamine therapy in the emergency department
- Acute Dissociation and Ketamine's Antidepressant and Anti-Suicidal Ideation Effects in a Midazolam-controlled Trial